Status

Invitation only clinical trials

Studies whose latest retrieved public registry status is Invitation only.

133active studies

0recruiting now

32countries represented

64largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Invitation onlyNot applicable

Effects of a Sugar-Based Synbiotic Product on Cardiometabolic and Intestinal Health (SUGAR-SYN BC3O)

Overweight AdultsCondition

Sugar-Based Synbiotic Product, Inulin-Containing Sugar ProductTreatment

Italy1 locations

Federico II UniversitySponsor

Updated 2026-09-08 · NCT07806383See eligibility →

Invitation onlyNot applicable

Quality of Recovery and Patient Satisfaction After Metabolic Surgery at a Tertiary Hospital in Gauteng (QoRPS-MS)

Obesity, Obesity (Disorder)Condition

Intervention not listedTreatment

South Africa1 locations

Sefako Makgatho Health Sciences UniversitySponsor

Updated 2026-09-04 · NCT07804290See eligibility →

Invitation onlyNot applicable

Respiratory Effects of Obesity in Children: Longitudinal Consequences After 6 Years of Aging

Childhood ObesityCondition

Intervention not listedTreatment

United States1 locations

University of Texas Southwestern Medical CenterSponsor

Updated 2026-09-03 · NCT06447246See eligibility →

Invitation onlyNot applicable

The Effect of Adiposity on Muscle and Microvascular Function in HFpEF

Heart Failure With Preserved Ejection Fraction (HFPEF)Condition

Weight loss SOC Treatment with second generation anti-diabetic medicationsTreatment

United States1 locations

University of Texas Southwestern Medical CenterSponsor

Updated 2026-09-03 · NCT06930495See eligibility →

Invitation onlyNot applicable

Free Fatty Acid Effects In Type 2 Diabetes

Type 2 Diabetes, Cardiovascular DiseaseCondition

Omega-3 Fatty Acids, Semaglutide 0.25 mgTreatment

United Kingdom1 locations

University of UlsterSponsor

Updated 2026-09-01 · NCT07677995See eligibility →

Invitation onlyNot applicable

Impact of Chronotype-Based Time-Restricted Eating on Visceral Fat and Metabolic Health in Physically Inactive Adults With Central Obesity

Central Obesity, Time Restricted EatingCondition

Chronotype-matched time-restricted eating, Chronotype-unmatched time-restricted eatingTreatment

China1 locations

Chinese University of Hong KongSponsor

Updated 2026-08-31 · NCT07062315See eligibility →

Invitation onlyNot applicable

Videolaryngoscopes in the Morbidly Obese

Obesity Difficult Airway Airway ManagementCondition

Airway managementTreatment

Poland1 locations

Uniwersytet Radomski im. Kazimierza PułaskiegoSponsor

Updated 2026-08-26 · NCT07787468See eligibility →

Invitation onlyNot applicable

Cities for Better Health Childhood Obesity Prevention Initiative

ObesityCondition

Community-based intervention packagesTreatment

Australia, Brazil6 locations

Novo Nordisk A/SSponsor

Updated 2026-08-21 · NCT06855563See eligibility →

Invitation onlyPhase 2

An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder

Obesity, Methamphetamine Use DisorderCondition

TirzepatideTreatment

United States1 locations

University of Texas Southwestern Medical CenterSponsor

Updated 2026-08-21 · NCT07693608See eligibility →

Invitation onlyNot applicable

Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife

Physical Inactivity, WalkingCondition

Adaptive Daily Goal Setting, Interim Goal PromptTreatment

United States1 locations

Milton S. Hershey Medical CenterSponsor

Updated 2026-08-12 · NCT05826379See eligibility →

Invitation onlyNot applicable

Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations

Diabetes, Cardiovascular DiseaseCondition

Intervention not listedTreatment

United States1 locations

National Human Genome Research Institute (NHGRI)Sponsor

Updated 2026-08-07 · NCT01316783See eligibility →

Invitation onlyNot applicable

Supporting Decisions on Lifestyle Change

ObesityCondition

MyHealthPath Tool, MyHealthPath GuideTreatment

United States1 locations

University of FloridaSponsor

Updated 2026-08-06 · NCT06206954See eligibility →

Invitation onlyNot applicable

A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

ObesityCondition

SemaglutideTreatment

Spain, Switzerland30 locations

Novo Nordisk A/SSponsor

Updated 2026-08-04 · NCT07055607See eligibility →

Invitation onlyNot applicable

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Overweight (BMI > 25)Condition

AI-Guided Microbiome-Targeted Nutritional Supplement, Matching Placebo (B)Treatment

Turkey (Türkiye)1 locations

Varol TUNALISponsor

Updated 2026-07-30 · NCT07736547See eligibility →

Invitation onlyNot applicable

Pilot Trial of the Move Healthier Group

Obesity, OverweightCondition

Move Healthier InterventionTreatment

United States1 locations

Dartmouth-Hitchcock Medical CenterSponsor

Updated 2026-07-28 · NCT07406568See eligibility →

Invitation onlyPhase 2

Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)

Pseudohypoparathyroidism Type 1a, ObesityCondition

SetmelanotideTreatment

United States1 locations

Massachusetts General HospitalSponsor

Updated 2026-07-23 · NCT07496463See eligibility →

Invitation onlyNot applicable

A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

Pregnancy, ObesityCondition

No InterventionTreatment

United States2 locations

Novo Nordisk A/SSponsor

Updated 2026-07-21 · NCT05503927See eligibility →

Invitation onlyNot applicable

Effectiveness of a Care Model for Sarcopenic Obesity in Older Adults on Fat Mass, Muscle Mass, Muscle Strength, and Physical Performance

Sarcopenic ObesityCondition

sarcopenic obesity modification programeTreatment

Thailand1 locations

Srinakharinwirot UniversitySponsor

Updated 2026-07-21 · NCT07523672See eligibility →

Invitation onlyPhase 4

Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women

Obesity, MenopauseCondition

semaglutide or tirzepatide, Lifestyle modification interventionTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-07-20 · NCT07057310See eligibility →

Invitation onlyPhase 4

Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver DiseaseCondition

TirzepatideTreatment

Taiwan1 locations

National Taiwan University Clinical Trial CenterSponsor

Updated 2026-07-20 · NCT07707778See eligibility →

Invitation onlyNot applicable

MRI Assessment of Body Composition in Bariatric Surgery

Obesity (BMI>30)Condition

MRITreatment

Poland1 locations

University of Warmia and Mazury in OlsztynSponsor

Updated 2026-07-17 · NCT07711925See eligibility →

Invitation onlyNot applicable

Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying

Gastric Emptying, Glucagon-Like Peptide-1 Receptor AgonistsCondition

Ultrasound of gastric contentsTreatment

United States1 locations

Wael Saasouh, MDSponsor

Updated 2026-07-16 · NCT07140289See eligibility →

Invitation onlyNot applicable

Prevalence and Determinants of Obesity in PKU Patients

Phenylketonuria (PKU)Condition

Intervention not listedTreatment

Switzerland1 locations

Christel TranSponsor

Updated 2026-07-14 · NCT07703020See eligibility →

Invitation onlyNot applicable

Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity

Abdominal Obesity, Abdominal Obesity-Metabolic SyndromeCondition

conventional balanced, low-calorie diet 1500 k/cal for 12 weeks, aerobic training programTreatment

Egypt1 locations

Cairo UniversitySponsor

Updated 2026-07-07 · NCT07686601See eligibility →

Invitation onlyPhase 4

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Infections Joint Prosthetic, Overweight or ObesityCondition

Cephalexin, DoxycyclineTreatment

United States2 locations

Mayo ClinicSponsor

Updated 2026-07-06 · NCT04297592See eligibility →

Invitation onlyPhase 2

Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)

Overweight, ObesityCondition

Initial in-person individual diet and exercise counseling (N vs. Y), Thrice weekly diet and exercise text messages (N vs. Y)Treatment

United States1 locations

Memorial Sloan Kettering Cancer CenterSponsor

Updated 2026-07-06 · NCT03851458See eligibility →

Invitation onlyNot applicable

The Efficacy and Safety of Herbal Medicine Treatment for Obese Patients With Spinal and Joint Pain

Obesity and OverweightCondition

Herbal medicine treatment, Life GuidanceTreatment

South Korea1 locations

Jaseng Medical FoundationSponsor

Updated 2026-07-02 · NCT06859697See eligibility →

Invitation onlyNot applicable

Immersive Physical Activity Program for Overweight Schoolchildren

Childhood Overweight and Obesity Immersive Physical ActivityCondition

RVI_Experimental_Immersive Virtual Reality Exergame Program, RVI_ControGroup_Immersive Virtual Reality Exergame ProgramTreatment

Spain1 locations

University of VigoSponsor

Updated 2026-07-02 · NCT07681856See eligibility →

Invitation onlyNot applicable

Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

Diabetes Mellitus, Type 2, ObesityCondition

No treatment givenTreatment

South Korea1 locations

Novo Nordisk A/SSponsor

Updated 2026-06-29 · NCT07673822See eligibility →

Invitation onlyNot applicable

Effects of Mulberry Leaf Extract Formulation on Postprandial Glycemic Levels in Obese Children and Adolescents

ObesityCondition

Reducose, PlaceboTreatment

Italy1 locations

University of Bari Aldo MoroSponsor

Updated 2026-06-22 · NCT07494253See eligibility →

Invitation onlyNot applicable

Healthy Eating for My Infant: A Community- Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and Feeding

Obesity & OverweightCondition

Healthy Eating for My Infant (HEMI)Treatment

United States1 locations

University of CincinnatiSponsor

Updated 2026-06-11 · NCT07284108See eligibility →

Invitation onlyNot applicable

Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

ObesityCondition

Incretin-based therapies (GLP-1 and GLP-1/GIP)Treatment

United States1 locations

Indiana UniversitySponsor

Updated 2026-06-10 · NCT07640139See eligibility →

Invitation onlyNot applicable

The LEADS Trial (Linking Exericise for Advancing Daily Stress Management)

Physical Activity, Childhood ObesityCondition

Treatment, Health EducationTreatment

United States2 locations

University of South CarolinaSponsor

Updated 2026-06-09 · NCT07176234See eligibility →

Invitation onlyNot applicable

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

Cardiometabolic Conditions, Hypertension (HTN)Condition

PILI (Partnership for Improving Lifestyle Intervention) Pasifika ProgramTreatment

United States2 locations

University of HawaiiSponsor

Updated 2026-06-09 · NCT07387393See eligibility →

Invitation onlyNot applicable

EFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALS

Metabolic Syndrome, DiabetesCondition

Intervention with yerba mate extract or placeboTreatment

Brazil1 locations

Universidade Federal da Fronteira SulSponsor

Updated 2026-05-29 · NCT07000825See eligibility →

Invitation onlyNot applicable

Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB

Obesity and Obesity-related Medical ConditionsCondition

FLOW Lifestyle Medicine ClinicTreatment

United States1 locations

University of Alabama at BirminghamSponsor

Updated 2026-05-22 · NCT06989281See eligibility →

Invitation onlyNot applicable

A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China

Type 2 DiabetesCondition

Intervention not listedTreatment

China1 locations

Novo Nordisk A/SSponsor

Updated 2026-05-20 · NCT07456774See eligibility →

Invitation onlyNot applicable

HIBOC = Hepatic Imaging Biomarkers in Obese Children

Elastography, Shear Wave ElastographyCondition

Intervention not listedTreatment

Sweden1 locations

Sahlgrenska University HospitalSponsor

Updated 2026-05-18 · NCT06463223See eligibility →

Invitation onlyNot applicable

Preoperative Use of a Magnetically Controlled Capsule Endoscopy in Patients Undergoing Bariatric Surgery

Obesity, Bariatric Surgery CandidateCondition

Magnetically Controlled Capsule Endoscopy (MCCE)Treatment

United States1 locations

Jerry DangSponsor

Updated 2026-05-14 · NCT07587437See eligibility →

Invitation onlyNot applicable

Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance

Insulin Resistance, Insulin SensitivityCondition

Intervention not listedTreatment

United States1 locations

Stanford UniversitySponsor

Updated 2026-05-13 · NCT04708535See eligibility →

Invitation onlyNot applicable

Using Online Tools to Increase Weight Loss in Primary Care

ObesityCondition

Connect4Health Engage, Connect4Health DiscoverTreatment

United States1 locations

University of FloridaSponsor

Updated 2026-05-11 · NCT06928571See eligibility →

Invitation onlyNot applicable

Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal

Cardiovascular Risk FactorCondition

Multicomponent Virtual Lifestyle InterventionTreatment

United States1 locations

Truemedicine IncSponsor

Updated 2026-05-07 · NCT07572721See eligibility →

Invitation onlyNot applicable

Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)

Obesity, Obesity, MorbidCondition

Endoscopic management of fistulas with stents or vacum therapyTreatment

Portugal1 locations

Unidade Local de Saúde Santa MariaSponsor

Updated 2026-05-06 · NCT06862479See eligibility →

Invitation onlyNot applicable

Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2Condition

SemaglutideTreatment

South Korea1 locations

Novo Nordisk A/SSponsor

Updated 2026-05-05 · NCT05689372See eligibility →

Invitation onlyNot applicable

24-h Energy Expenditure and Anti-obesity Medication

ObesityCondition

anti obesity medicationTreatment

Italy1 locations

University of PisaSponsor

Updated 2026-05-05 · NCT07041983See eligibility →

Invitation onlyNot applicable

Real-world Exploration of Digital iNnovation in the Management of Excess Weight

Obesity, Obesity & OverweightCondition

Digital Weight Management ProgrammeTreatment

United Kingdom1 locations

Guy's and St Thomas' NHS Foundation TrustSponsor

Updated 2026-04-29 · NCT07283978See eligibility →

Invitation onlyNot applicable

Pilot Validation of the STELA Preventive Medicine Platform to Reduce Modifiable Health Risk Factors in Adults (CPM-STELA)

Cardiovascular Risk Factors, Insulin ResistanceCondition

STELA Digital Preventive Medicine Platform, Comprehensive Preventive Health AssessmentTreatment

Czechia1 locations

Nemocnice AGEL Trinec-Podlesi a.s.Sponsor

Updated 2026-04-27 · NCT07551960See eligibility →

Invitation onlyPhase 4

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Diabetes Mellitus, Type 2, Liver FibrosisCondition

early time restricted Mediterranean diet, MysimbaTreatment

Netherlands1 locations

Carmen DietvorstSponsor

Updated 2026-04-21 · NCT06845345See eligibility →

Invitation onlyNot applicable

Online Dietary Weight Loss Program for Arab Adults: A Randomized Controlled Trial

Overweight and ObesityCondition

Online Lifestyle and Dietary Program, Usual Dietary CareTreatment

Saudi Arabia1 locations

Asma YahyaSponsor

Updated 2026-04-09 · NCT07518875See eligibility →

Invitation onlyPhase 4

Semaglutide vs Sitagliptin

Liver Transplant; Complications, Diabetes MellitusCondition

Semaglutide Treatment, Sitagliptin 100mgTreatment

Canada1 locations

University Health Network, TorontoSponsor

Updated 2026-04-06 · NCT05195944See eligibility →

Invitation onlyNot applicable

Lifestyle Program Focused on Nourishment, Well-Being, and Health Behaviors in Women With Obesity

Obesity and Cardiovascular RiskCondition

lifestyle change programTreatment

Canada1 locations

Heather ConradsonSponsor

Updated 2026-04-06 · NCT07404150See eligibility →

Invitation onlyNot applicable

A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change

Obesity & Overweight, Weight LossCondition

Intervention not listedTreatment

Taiwan1 locations

National Taiwan University HospitalSponsor

Updated 2026-03-30 · NCT07239167See eligibility →

Invitation onlyNot applicable

Whole-body Vibration Training on the Elderly With Combined Bilateral Knee Osteoarthritis

Knee OA, Sarcopenic ObesityCondition

Whole-body vibration trainingTreatment

Egypt1 locations

Beni-Suef UniversitySponsor

Updated 2026-03-18 · NCT07478861See eligibility →

Invitation onlyNot applicable

Group Medical Appointments for Intensive Lifestyle Treatment for Obesity in Cleveland Clinic Primary Care Practices

Obesity & OverweightCondition

ACTIVATE OCTreatment

United States1 locations

Anita Misra-HebertSponsor

Updated 2026-03-11 · NCT07268417See eligibility →

Invitation onlyNot applicable

Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemical Biomarkers, and Perceived Exertion in Adults With Obesity

Obesity & OverweightCondition

Intervention, InterventionTreatment

Mexico1 locations

Centro Universitario de Tlajomulco, Universidad de GuadalajaraSponsor

Updated 2026-03-03 · NCT07444736See eligibility →

Invitation onlyNot applicable

Influence of the Urolithin A on the Population With BMI Higher Than 30 During Restricted Eating.

Obesity & OverweightCondition

Urolithin A 500mg, PlaceboTreatment

Czechia1 locations

Charles University, Czech RepublicSponsor

Updated 2026-02-19 · NCT07377136See eligibility →

Invitation onlyNot applicable

010Fit'R - Healthy Lifestyle Interventions for Children With Overweight

Overweight, ChildrenCondition

010 Fit'R interventionTreatment

Netherlands1 locations

Erasmus Medical CenterSponsor

Updated 2026-02-19 · NCT07419503See eligibility →

Invitation onlyNot applicable

Effects of Short Isokinetic Eccentric Resistance Training on Neuromuscular Induced Adaptations

Obesity, Physical InactivityCondition

ECC ISO, CON ISOTreatment

Malaysia1 locations

Universiti Sains MalaysiaSponsor

Updated 2026-02-12 · NCT07407621See eligibility →

Invitation onlyPhase 2

A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

Hypothalamic ObesityCondition

BivamelagonTreatment

United Kingdom, United States9 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-02-10 · NCT07156578See eligibility →

Invitation onlyNot applicable

Use of a Mobile Application by Parents to Prevent Obesity in Their Children Apply for Your Health

Obesity, OverweightCondition

Applícate por tu saludTreatment

Mexico1 locations

Hospital Infantil de Mexico Federico GomezSponsor

Updated 2026-02-05 · NCT07376252See eligibility →

This page shows the first 60 studies. Use the full search to filter all matches.

Related statuses

Recruiting now1,541 Opening soon671 Active, not recruiting664

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.